{"entity":{"type":"insider","cik":"0001267075","url":"/insider/0001267075","json_url":"/insider/0001267075.json","name":"AVENTIS HOLDINGS INC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":44,"n_filings":34,"first":"2003-11-05","last":"2006-09-05","span_basis":"filed_date"},"name_variants":[{"name":"AVENTIS HOLDINGS INC","source":"filing","n_filings":33,"first_seen":"2003-11-26","last_seen":"2006-09-05"},{"name":"AVENITS HOLDINGS INC","source":"filing","n_filings":1,"first_seen":"2003-11-05","last_seen":"2003-11-05"}],"transactions":[{"id":4619185,"accession":"0001356774-06-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000014","line_url":"/filing/0001356774-06-000014#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; Aventis Inc.","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33530.0,"shares_display":"33,530","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":132778.8,"total_display":"132,778.80","total_whole":"132,779","shares_owned_after":3777541.0,"shares_owned_after_display":"3,777,541","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-31","filed_date":"2006-09-05","scope":"insider"},{"id":3992571,"accession":"0001356774-06-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000013","line_url":"/filing/0001356774-06-000013#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; Aventis Inc.","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":41580.0,"total_display":"41,580.00","total_whole":"41,580","shares_owned_after":3811071.0,"shares_owned_after_display":"3,811,071","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-30","filed_date":"2006-09-01","scope":"insider"},{"id":4259257,"accession":"0001356774-06-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001356774-06-000012","line_url":"/filing/0001356774-06-000012#line-2","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13484.0,"shares_display":"13,484","price_per_share":3.89,"price_display":"3.89","price_state":"stated","total_value":52452.76,"total_display":"52,452.76","total_whole":"52,453","shares_owned_after":3821571.0,"shares_owned_after_display":"3,821,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-29","filed_date":"2006-08-30","scope":"insider"},{"id":4259253,"accession":"0001356774-06-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000012","line_url":"/filing/0001356774-06-000012#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36739.0,"shares_display":"36,739","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":143649.49,"total_display":"143,649.49","total_whole":"143,649","shares_owned_after":3835055.0,"shares_owned_after_display":"3,835,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-28","filed_date":"2006-08-30","scope":"insider"},{"id":3792207,"accession":"0001356774-06-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000011","line_url":"/filing/0001356774-06-000011#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19208.0,"shares_display":"19,208","price_per_share":3.94,"price_display":"3.94","price_state":"stated","total_value":75679.52,"total_display":"75,679.52","total_whole":"75,680","shares_owned_after":3871794.0,"shares_owned_after_display":"3,871,794","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-21","filed_date":"2006-08-23","scope":"insider"},{"id":3950530,"accession":"0001356774-06-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000010","line_url":"/filing/0001356774-06-000010#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23902.0,"shares_display":"23,902","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":92022.7,"total_display":"92,022.70","total_whole":"92,023","shares_owned_after":3891002.0,"shares_owned_after_display":"3,891,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-17","filed_date":"2006-08-21","scope":"insider"},{"id":4357391,"accession":"0001356774-06-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000009","line_url":"/filing/0001356774-06-000009#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; Aventis Inc.","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41355.0,"shares_display":"41,355","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":159216.75,"total_display":"159,216.75","total_whole":"159,217","shares_owned_after":3914904.0,"shares_owned_after_display":"3,914,904","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-16","filed_date":"2006-08-18","scope":"insider"},{"id":2718243,"accession":"0001267075-06-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267075-06-000001","line_url":"/filing/0001267075-06-000001#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; Aventis Inc.","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21212.0,"shares_display":"21,212","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":82726.8,"total_display":"82,726.80","total_whole":"82,727","shares_owned_after":3956259.0,"shares_owned_after_display":"3,956,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-15","filed_date":"2006-08-16","scope":"insider"},{"id":4511819,"accession":"0001356774-06-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001356774-06-000008","line_url":"/filing/0001356774-06-000008#line-2","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34700.0,"shares_display":"34,700","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":135330.0,"total_display":"135,330.00","total_whole":"135,330","shares_owned_after":3977471.0,"shares_owned_after_display":"3,977,471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-14","filed_date":"2006-08-14","scope":"insider"},{"id":4511805,"accession":"0001356774-06-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000008","line_url":"/filing/0001356774-06-000008#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":117300.0,"total_display":"117,300.00","total_whole":"117,300","shares_owned_after":4012171.0,"shares_owned_after_display":"4,012,171","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-11","filed_date":"2006-08-14","scope":"insider"},{"id":3713514,"accession":"0001356774-06-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000007","line_url":"/filing/0001356774-06-000007#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42695.0,"shares_display":"42,695","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":171206.95,"total_display":"171,206.95","total_whole":"171,207","shares_owned_after":4042171.0,"shares_owned_after_display":"4,042,171","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-10","filed_date":"2006-08-14","scope":"insider"},{"id":5581394,"accession":"0001356774-06-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000006","line_url":"/filing/0001356774-06-000006#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65845.0,"shares_display":"65,845","price_per_share":5.42,"price_display":"5.42","price_state":"stated","total_value":356879.9,"total_display":"356,879.90","total_whole":"356,880","shares_owned_after":4084866.0,"shares_owned_after_display":"4,084,866","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-04-04","filed_date":"2006-04-06","scope":"insider"},{"id":3750783,"accession":"0001356774-06-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000005","line_url":"/filing/0001356774-06-000005#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; Aventis Inc.","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28173.0,"shares_display":"28,173","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":153542.85,"total_display":"153,542.85","total_whole":"153,543","shares_owned_after":4150711.0,"shares_owned_after_display":"4,150,711","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-04-03","filed_date":"2006-04-05","scope":"insider"},{"id":3517989,"accession":"0001356774-06-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000004","line_url":"/filing/0001356774-06-000004#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; Aventis Inc.","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9526.0,"shares_display":"9,526","price_per_share":5.31,"price_display":"5.31","price_state":"stated","total_value":50583.06,"total_display":"50,583.06","total_whole":"50,583","shares_owned_after":4178884.0,"shares_owned_after_display":"4,178,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-28","filed_date":"2006-03-30","scope":"insider"},{"id":3992569,"accession":"0001356774-06-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000003","line_url":"/filing/0001356774-06-000003#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15843.0,"shares_display":"15,843","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":84918.48,"total_display":"84,918.48","total_whole":"84,918","shares_owned_after":4188410.0,"shares_owned_after_display":"4,188,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-21","filed_date":"2006-03-23","scope":"insider"},{"id":4036329,"accession":"0001356774-06-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000002","line_url":"/filing/0001356774-06-000002#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; Aventis Inc.","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12599.0,"shares_display":"12,599","price_per_share":5.31,"price_display":"5.31","price_state":"stated","total_value":66900.69,"total_display":"66,900.69","total_whole":"66,901","shares_owned_after":1860532.0,"shares_owned_after_display":"1,860,532","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-20","filed_date":"2006-03-22","scope":"insider"},{"id":4721538,"accession":"0001356774-06-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001356774-06-000001","line_url":"/filing/0001356774-06-000001#line-2","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23083.0,"shares_display":"23,083","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":122801.56,"total_display":"122,801.56","total_whole":"122,802","shares_owned_after":1873131.0,"shares_owned_after_display":"1,873,131","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-17","filed_date":"2006-03-20","scope":"insider"},{"id":4721532,"accession":"0001356774-06-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001356774-06-000001","line_url":"/filing/0001356774-06-000001#line-1","is_derivative":false,"issuer_cik":"0001018710","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001018710","owner_cik":null,"owner_name":"Aventis Inc.; AVENTIS HOLDINGS INC","owner_display_name":"Aventis Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82434.0,"shares_display":"82,434","price_per_share":5.44,"price_display":"5.44","price_state":"stated","total_value":448440.96,"total_display":"448,440.96","total_whole":"448,441","shares_owned_after":1896214.0,"shares_owned_after_display":"1,896,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-16","filed_date":"2006-03-20","scope":"insider"},{"id":1268777,"accession":"0000217028-05-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-05-000010","line_url":"/filing/0000217028-05-000010#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":6.2,"price_display":"6.20","price_state":"stated","total_value":179800.0,"total_display":"179,800.00","total_whole":"179,800","shares_owned_after":1978648.0,"shares_owned_after_display":"1,978,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-11-08","filed_date":"2005-11-10","scope":"insider"},{"id":1202586,"accession":"0000217028-05-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000217028-05-000009","line_url":"/filing/0000217028-05-000009#line-2","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":6.22,"price_display":"6.22","price_state":"stated","total_value":223920.0,"total_display":"223,920.00","total_whole":"223,920","shares_owned_after":2007648.0,"shares_owned_after_display":"2,007,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-11-07","filed_date":"2005-11-08","scope":"insider"},{"id":1202585,"accession":"0000217028-05-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-05-000009","line_url":"/filing/0000217028-05-000009#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44000.0,"shares_display":"44,000","price_per_share":5.87,"price_display":"5.87","price_state":"stated","total_value":258280.0,"total_display":"258,280.00","total_whole":"258,280","shares_owned_after":2043648.0,"shares_owned_after_display":"2,043,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-11-04","filed_date":"2005-11-08","scope":"insider"},{"id":1407492,"accession":"0000217028-05-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-05-000008","line_url":"/filing/0000217028-05-000008#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":5.24,"price_display":"5.24","price_state":"stated","total_value":172920.0,"total_display":"172,920.00","total_whole":"172,920","shares_owned_after":2087648.0,"shares_owned_after_display":"2,087,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-28","filed_date":"2005-11-01","scope":"insider"},{"id":1680566,"accession":"0000217028-05-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-05-000007","line_url":"/filing/0000217028-05-000007#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63000.0,"shares_display":"63,000","price_per_share":5.03,"price_display":"5.03","price_state":"stated","total_value":316890.0,"total_display":"316,890.00","total_whole":"316,890","shares_owned_after":2120648.0,"shares_owned_after_display":"2,120,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-27","filed_date":"2005-10-28","scope":"insider"},{"id":1532398,"accession":"0001267075-05-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267075-05-000004","line_url":"/filing/0001267075-05-000004#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10392.0,"shares_display":"10,392","price_per_share":5.52,"price_display":"5.52","price_state":"stated","total_value":57363.84,"total_display":"57,363.84","total_whole":"57,364","shares_owned_after":2183648.0,"shares_owned_after_display":"2,183,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-16","filed_date":"2005-09-20","scope":"insider"},{"id":1325278,"accession":"0001267075-05-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267075-05-000003","line_url":"/filing/0001267075-05-000003#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28272.0,"shares_display":"28,272","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":162564.0,"total_display":"162,564.00","total_whole":"162,564","shares_owned_after":2194040.0,"shares_owned_after_display":"2,194,040","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-13","filed_date":"2005-09-14","scope":"insider"},{"id":1311576,"accession":"0001267075-05-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267075-05-000002","line_url":"/filing/0001267075-05-000002#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"ING","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33200.0,"shares_display":"33,200","price_per_share":5.81,"price_display":"5.81","price_state":"stated","total_value":192892.0,"total_display":"192,892.00","total_whole":"192,892","shares_owned_after":2222312.0,"shares_owned_after_display":"2,222,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-12","filed_date":"2005-09-13","scope":"insider"},{"id":1383627,"accession":"0001267075-05-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267075-05-000001","line_url":"/filing/0001267075-05-000001#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":143750.0,"total_display":"143,750.00","total_whole":"143,750","shares_owned_after":2255512.0,"shares_owned_after_display":"2,255,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-08","filed_date":"2005-09-12","scope":"insider"},{"id":1468153,"accession":"0000217028-05-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-05-000005","line_url":"/filing/0000217028-05-000005#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40253.0,"shares_display":"40,253","price_per_share":5.82,"price_display":"5.82","price_state":"stated","total_value":234272.46,"total_display":"234,272.46","total_whole":"234,272","shares_owned_after":2280512.0,"shares_owned_after_display":"2,280,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-07","filed_date":"2005-09-09","scope":"insider"},{"id":1289809,"accession":"0000217028-05-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-05-000004","line_url":"/filing/0000217028-05-000004#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165260.0,"shares_display":"165,260","price_per_share":5.97,"price_display":"5.97","price_state":"stated","total_value":986602.2,"total_display":"986,602.20","total_whole":"986,602","shares_owned_after":2320765.0,"shares_owned_after_display":"2,320,765","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-06","filed_date":"2005-09-08","scope":"insider"},{"id":1647520,"accession":"0000217028-05-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000217028-05-000003","line_url":"/filing/0000217028-05-000003#line-3","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10091.0,"shares_display":"10,091","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":59536.9,"total_display":"59,536.90","total_whole":"59,537","shares_owned_after":2486025.0,"shares_owned_after_display":"2,486,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-02","filed_date":"2005-09-06","scope":"insider"},{"id":1647519,"accession":"0000217028-05-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000217028-05-000003","line_url":"/filing/0000217028-05-000003","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49580.0,"shares_display":"49,580","price_per_share":5.920084711577249,"price_display":"5.92","price_state":"stated","total_value":293517.8,"total_display":"293,517.80","total_whole":"293,518","shares_owned_after":2496116.0,"shares_owned_after_display":"2,496,116","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-01","filed_date":"2005-09-06","scope":"insider","n_lines":2},{"id":1252957,"accession":"0000217028-05-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-05-000002","line_url":"/filing/0000217028-05-000002#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3611.0,"shares_display":"3,611","price_per_share":6.55,"price_display":"6.55","price_state":"stated","total_value":23652.05,"total_display":"23,652.05","total_whole":"23,652","shares_owned_after":2545696.0,"shares_owned_after_display":"2,545,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-07-25","filed_date":"2005-07-27","scope":"insider"},{"id":1389377,"accession":"0000217028-05-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000217028-05-000001","line_url":"/filing/0000217028-05-000001#line-2","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.56,"price_display":"6.56","price_state":"stated","total_value":65600.0,"total_display":"65,600.00","total_whole":"65,600","shares_owned_after":2549307.0,"shares_owned_after_display":"2,549,307","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-07-22","filed_date":"2005-07-25","scope":"insider"},{"id":1389376,"accession":"0000217028-05-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-05-000001","line_url":"/filing/0000217028-05-000001#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106636.0,"shares_display":"106,636","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":718726.64,"total_display":"718,726.64","total_whole":"718,727","shares_owned_after":2559307.0,"shares_owned_after_display":"2,559,307","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-07-21","filed_date":"2005-07-25","scope":"insider"},{"id":561409,"accession":"0000217028-04-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000217028-04-000001","line_url":"/filing/0000217028-04-000001#line-2","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":25200.0,"total_display":"25,200.00","total_whole":"25,200","shares_owned_after":2700643.0,"shares_owned_after_display":"2,700,643","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-07-16","filed_date":"2004-07-19","scope":"insider"},{"id":561408,"accession":"0000217028-04-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000217028-04-000001","line_url":"/filing/0000217028-04-000001#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"INTROGEN THERAPEUTICS INC","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":104400.0,"total_display":"104,400.00","total_whole":"104,400","shares_owned_after":2707643.0,"shares_owned_after_display":"2,707,643","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-07-15","filed_date":"2004-07-19","scope":"insider"},{"id":547668,"accession":"0001267093-04-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-04-000003","line_url":"/filing/0001267093-04-000003#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS PHARMACEUTICALS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22100.0,"shares_display":"22,100","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":77571.0,"total_display":"77,571.00","total_whole":"77,571","shares_owned_after":2616000.0,"shares_owned_after_display":"2,616,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-14","filed_date":"2004-01-16","scope":"insider"},{"id":588213,"accession":"0001267093-04-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001267093-04-000002","line_url":"/filing/0001267093-04-000002#line-2","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC; AVENTIS PHARMACEUTICALS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31000.0,"shares_display":"31,000","price_per_share":3.49,"price_display":"3.49","price_state":"stated","total_value":108190.0,"total_display":"108,190.00","total_whole":"108,190","shares_owned_after":2638100.0,"shares_owned_after_display":"2,638,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-13","filed_date":"2004-01-14","scope":"insider"},{"id":588212,"accession":"0001267093-04-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-04-000002","line_url":"/filing/0001267093-04-000002#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC; AVENTIS PHARMACEUTICALS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95900.0,"shares_display":"95,900","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":322224.0,"total_display":"322,224.00","total_whole":"322,224","shares_owned_after":2669100.0,"shares_owned_after_display":"2,669,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-12","filed_date":"2004-01-14","scope":"insider"},{"id":466253,"accession":"0001267093-04-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-04-000001","line_url":"/filing/0001267093-04-000001#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC; AVENTIS PHARMACEUTICALS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59000.0,"shares_display":"59,000","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":187620.0,"total_display":"187,620.00","total_whole":"187,620","shares_owned_after":2765000.0,"shares_owned_after_display":"2,765,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-09","filed_date":"2004-01-12","scope":"insider"},{"id":92947,"accession":"0001267093-03-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-03-000002","line_url":"/filing/0001267093-03-000002#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC; AVENTIS PHARMACEUTICALS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15012.0,"shares_display":"15,012","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":47287.8,"total_display":"47,287.80","total_whole":"47,288","shares_owned_after":2824000.0,"shares_owned_after_display":"2,824,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-25","filed_date":"2003-11-26","scope":"insider"},{"id":21342,"accession":"0001267093-03-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001267093-03-000001","line_url":"/filing/0001267093-03-000001#line-2","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS PHARMACEUTICALS INC; AVENITS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25988.0,"shares_display":"25,988","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":85760.4,"total_display":"85,760.40","total_whole":"85,760","shares_owned_after":2839012.0,"shares_owned_after_display":"2,839,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-04","filed_date":"2003-11-05","scope":"insider"},{"id":21341,"accession":"0001267093-03-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-03-000001","line_url":"/filing/0001267093-03-000001#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS PHARMACEUTICALS INC; AVENITS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135000.0,"shares_display":"135,000","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":427950.0,"total_display":"427,950.00","total_whole":"427,950","shares_owned_after":2865000.0,"shares_owned_after_display":"2,865,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-03","filed_date":"2003-11-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001018710","name":"INTROGEN THERAPEUTICS INC","url":"/issuer/0001018710","role":"Ten percent owner, Other","n_filings":29,"first_seen":"2004-07-19","last_seen":"2006-09-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000946840","name":"VIROPHARMA INC","url":"/issuer/0000946840","role":"Other","n_filings":5,"first_seen":"2003-11-05","last_seen":"2004-01-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001267075","retrieved_at":"2026-08-25T08:19:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}